Fischer Medical Ventures Share Price
Sector: Chemical Manufacturing
879.00 +31.55 (3.72%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
840.00
Today’s High
880.05
52 Week Low
573.60
52 Week High
919.00
Key Metrics
- Market Cap (In Cr) 5652.5
- Beta 0.79
- Div. Yield (%) 0.01
- P/B 16.02
- TTM P/E 12824.29
- Peg Ratio -
- Sector P/E 0
- D/E 0
- Open Price 854.95
- Prev Close 847.45
Fischer Medical Ventures Analysis
Price Analysis
-
1 Week0.65%
-
3 Months1.41%
-
6 Month21.99%
-
YTD20.37%
-
1 Year37.94%
Risk Meter
- 38% Low risk
- 38% Moderate risk
- 38% Balanced Risk
- 38% High risk
- 38% Extreme risk
Fischer Medical Ventures News
Q4 results today: IRCTC, Deepak Nitrate, SAIL, Cummins, Bata India on May 28
2 min read . 28 May 2025Fischer Medical Ventures Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 110.7
- Selling/ General/ Admin Expenses Total
- 2.58
- Depreciation/ Amortization
- 1.63
- Other Operating Expenses Total
- 13.21
- Total Operating Expense
- 109.01
- Operating Income
- 1.68
- Net Income Before Taxes
- 2.22
- Net Income
- 1.21
- Diluted Normalized EPS
- 0.22
- Period
- 2025
- Total Assets
- 457.37
- Total Liabilities
- 119.85
- Total Equity
- 337.52
- Tangible Book Valueper Share Common Eq
- 52.08
- Period
- 2025
- Cashfrom Operating Activities
- -86.25
- Cashfrom Investing Activities
- -125.36
- Cashfrom Financing Activities
- 314.92
- Net Changein Cash
- 103.31
- Period
- 2024
- Total Revenue
- 20.98
- Selling/ General/ Admin Expenses Total
- 0.38
- Depreciation/ Amortization
- 0.18
- Other Operating Expenses Total
- 2.29
- Total Operating Expense
- 19.3
- Operating Income
- 1.68
- Net Income Before Taxes
- 2.11
- Net Income
- 1.84
- Diluted Normalized EPS
- 1.65
- Period
- 2024
- Total Assets
- 86.32
- Total Liabilities
- 5.21
- Total Equity
- 81.11
- Tangible Book Valueper Share Common Eq
- 14.75
- Period
- 2024
- Cashfrom Operating Activities
- -7.59
- Cashfrom Investing Activities
- -31.2
- Cashfrom Financing Activities
- 37.11
- Net Changein Cash
- -1.68
- Period
- 2023
- Total Revenue
- 0.18
- Selling/ General/ Admin Expenses Total
- 0.05
- Other Operating Expenses Total
- 0.12
- Total Operating Expense
- 0.16
- Operating Income
- 0.02
- Net Income Before Taxes
- 0
- Net Income
- -0.04
- Diluted Normalized EPS
- -2.12
- Period
- 2023
- Total Assets
- 0.35
- Total Liabilities
- 0.62
- Total Equity
- -0.27
- Tangible Book Valueper Share Common Eq
- -15.47
- Period
- 2023
- Cashfrom Operating Activities
- -0.15
- Cashfrom Financing Activities
- 0.17
- Net Changein Cash
- 0.02
- Period
- 2022
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.08
- Other Operating Expenses Total
- 0.11
- Total Operating Expense
- 0.19
- Operating Income
- -0.19
- Net Income Before Taxes
- -0.2
- Net Income
- -0.23
- Diluted Normalized EPS
- -13.52
- Period
- 2022
- Total Assets
- 0.19
- Total Liabilities
- 0.42
- Total Equity
- -0.23
- Tangible Book Valueper Share Common Eq
- -13.34
- Period
- 2022
- Cashfrom Operating Activities
- -0.18
- Cashfrom Financing Activities
- 0.15
- Net Changein Cash
- -0.03
- Period
- 2021
- Total Revenue
- 0.16
- Selling/ General/ Admin Expenses Total
- 0.08
- Other Operating Expenses Total
- 0.1
- Total Operating Expense
- 0.18
- Operating Income
- -0.02
- Net Income Before Taxes
- -0.04
- Net Income
- 0.14
- Diluted Normalized EPS
- 8.18
- Period
- 2021
- Total Assets
- 0.25
- Total Liabilities
- 0.25
- Total Equity
- 0
- Tangible Book Valueper Share Common Eq
- 0.18
- Period
- 2021
- Cashfrom Operating Activities
- -0.06
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.06
- Period
- 2020
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.09
- Other Operating Expenses Total
- 0.12
- Total Operating Expense
- 0.21
- Operating Income
- -0.21
- Net Income Before Taxes
- -0.04
- Net Income
- -0.04
- Diluted Normalized EPS
- -2.39
- Period
- 2020
- Total Assets
- 0.14
- Total Liabilities
- 0.28
- Total Equity
- -0.14
- Tangible Book Valueper Share Common Eq
- -7.99
- Period
- 2020
- Cashfrom Operating Activities
- 0.01
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.01
- Period
- 2019
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.02
- Other Operating Expenses Total
- 0.17
- Total Operating Expense
- 0.19
- Operating Income
- -0.19
- Net Income Before Taxes
- 0.01
- Net Income
- 0
- Diluted Normalized EPS
- 0.26
- Period
- 2019
- Total Assets
- 0.11
- Total Liabilities
- 0.21
- Total Equity
- -0.1
- Tangible Book Valueper Share Common Eq
- -5.61
- Period
- 2019
- Cashfrom Operating Activities
- 0
- Cashfrom Financing Activities
- -0.03
- Net Changein Cash
- -0.03
- Period
- 2025-03-31
- Total Revenue
- 49.17
- Selling/ General/ Admin Expenses Total
- 0.94
- Depreciation/ Amortization
- 0.51
- Other Operating Expenses Total
- 6.42
- Total Operating Expense
- 47.18
- Operating Income
- 1.99
- Net Income Before Taxes
- 1.81
- Net Income
- 1.31
- Diluted Normalized EPS
- 0.09
- Period
- 2025-03-31
- Total Assets
- 457.37
- Total Liabilities
- 119.85
- Total Equity
- 337.52
- Tangible Book Valueper Share Common Eq
- 52.08
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -86.25
- Cashfrom Investing Activities
- -125.36
- Cashfrom Financing Activities
- 314.92
- Net Changein Cash
- 103.31
- Period
- 2024-12-31
- Total Revenue
- 11.75
- Selling/ General/ Admin Expenses Total
- 0.75
- Depreciation/ Amortization
- 0.56
- Other Operating Expenses Total
- 2.97
- Total Operating Expense
- 11.81
- Operating Income
- -0.06
- Net Income Before Taxes
- 0.12
- Net Income
- -0.29
- Diluted Normalized EPS
- -0.05
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 39.66
- Selling/ General/ Admin Expenses Total
- 0.51
- Depreciation/ Amortization
- 0.29
- Other Operating Expenses Total
- 2.53
- Total Operating Expense
- 39.62
- Operating Income
- 0.04
- Net Income Before Taxes
- 0.21
- Net Income
- 0.29
- Diluted Normalized EPS
- 0.07
- Period
- 2024-09-30
- Total Assets
- 140.72
- Total Liabilities
- 59.27
- Total Equity
- 81.45
- Tangible Book Valueper Share Common Eq
- 14.52
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -19.75
- Cashfrom Investing Activities
- 20.83
- Cashfrom Financing Activities
- -0.13
- Net Changein Cash
- 0.95
- Period
- 2024-06-30
- Total Revenue
- 10.12
- Selling/ General/ Admin Expenses Total
- 0.39
- Depreciation/ Amortization
- 0.28
- Other Operating Expenses Total
- 1.38
- Total Operating Expense
- 10.66
- Operating Income
- -0.54
- Net Income Before Taxes
- 0.08
- Net Income
- -0.12
- Diluted Normalized EPS
- -0.02
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 20.79
- Selling/ General/ Admin Expenses Total
- 0.34
- Depreciation/ Amortization
- 0.18
- Other Operating Expenses Total
- 2.04
- Total Operating Expense
- 19.02
- Operating Income
- 1.78
- Net Income Before Taxes
- 2.2
- Net Income
- 2.03
- Diluted Normalized EPS
- 0.52
- Period
- 2024-03-31
- Total Assets
- 86.32
- Total Liabilities
- 5.21
- Total Equity
- 81.11
- Tangible Book Valueper Share Common Eq
- 14.75
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -7.59
- Cashfrom Investing Activities
- -31.2
- Cashfrom Financing Activities
- 37.11
- Net Changein Cash
- -1.68
- Period
- 2023-12-31
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.03
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.12
- Total Operating Expense
- 0.15
- Operating Income
- -0.15
- Net Income Before Taxes
- -0.13
- Net Income
- -0.13
- Diluted Normalized EPS
- -0.76
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Fischer Medical Ventures Technical
Moving Average
SMA
- 5 Day848.36
- 10 Day850.53
- 20 Day860.33
- 50 Day835.26
- 100 Day806.2
- 300 Day734.61
Fischer Medical Ventures Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Indigo Paints
- 1168
- 1.55
- 0.13
- 1720
- 900.05
- 5567.07
- Laxmi Organic Industries
- 199.3
- 1.55
- 0.78
- 325.5
- 160.3
- 5521.94
- Fischer Medical Ventures
- 879
- 31.55
- 3.72
- 919
- 573.6
- 5652.5
- Balaji Amines
- 1783.8
- 44.05
- 2.53
- 2550.15
- 1112
- 5779.69
- National Fertilizers
- 101.15
- 0.69
- 0.69
- 169.95
- 70.94
- 4964.18
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Indigo Paints
- 39.59
- 5.43
- 16.43
- 10.8
- Laxmi Organic Industries
- 49.24
- 2.93
- 11.09
- 5.51
- Fischer Medical Ventures
- 3858.18
- 16.04
- 1.17
- 2.21
- Balaji Amines
- 34.4
- 2.94
- 19.4
- 16.15
- National Fertilizers
- 26.92
- 1.82
- 8.06
- 0.93
Fischer Medical Ventures Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-May-25
- Audited Results & Final Dividend
- 26-Mar-25
- Others
- 14-Feb-25
- Quarterly Results
- 03-Jan-25
- Others
- 13-Nov-24
- Quarterly Results
- 14-Aug-24
- Quarterly Results & Preferential issue
- 30-May-24
- Audited Results
- 04-May-24
- Others
- 12-Feb-24
- Quarterly Results
- 15-Dec-23
- Others
- Meeting Date
- Announced on
- Purpose
- 06-May-25
- 04-Apr-25
- POM
- 05-May-25
- 01-Apr-25
- POM
- 31-Jan-25
- 10-Jan-25
- EGM
- 17-Sept-24
- 14-Aug-24
- AGM
- 06-Jul-24
- 07-Jun-24
- POM
- 13-Jan-24
- 20-Dec-23
- EGM
- 23-Sept-23
- 29-Aug-23
- AGM
- 28-Apr-23
- 31-Mar-23
- EGM
- 29-Sept-22
- 05-Sept-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-25
- -
- -
- 0.05


